Tenax Therapeutics Inc — Quarterly Financial Statistics (NASDAQ:TENX) | MetaTrader

Open full chart

Financials

Overview Statement Statistics

Quarterly Annual

Cash from operating activities -3.53 M-6.97 M-6.26 M-9.15 M-13.41 M -35.8 M Cash from investing activities 0000— — Cash from financing activities 67 K23.56 M278 K3.06 M11.61 M 38.51 M Free cash flow -3.53 M-6.97 M-6.26 M-9.15 M-13.41 M -35.8 M

News

Cantor Fitzgerald initiates Tenax Therapeutics stock with overweight rating

Tenax Therapeutics stock gains as trial enrollment complete

Micron and BioNTech among market cap stock movers on Tuesday

Micron and Palantir among market cap stock movers on Tuesday

Tenax Therapeutics stock holds at Outperform at Leerink Partners

Tenax Therapeutics: Some Future Potential (NASDAQ:TENX)

Tenax Therapeutics Stock: A Speculative Buy (NASDAQ:TENX)

Tenax: Lower Variance In Phase 3 Has "Loaded The Dice" For An Asymmetric Repricing

Tesla, Goldman Sachs among market cap stock movers on Monday

Tenax Therapeutics’ phase 3 LEVEL study confirms enrollment target

Tenax Therapeutics stock price target raised to $25 from $14 at Guggenheim

Tenax Therapeutics director Rich Stuart buys $50,792 in stock